Common questions about Zyprexa (FAQ)
Q: Do you have to take Zyprexa forever, or is it for short-term use?
Studies and official information indicate that olanzapine has been evaluated for both short-term acute treatment and long-term maintenance therapy. It is used acutely for episodes like mania and for long-term use to help maintain improvement and prevent symptoms from recurring in conditions such as schizophrenia and bipolar disorder. The duration of use in official studies has varied, and decisions about length of therapy are clinical matters.
Q: Is it true that Zyprexa can cause weight gain?
Yes, weight gain is a common adverse reaction and a recognized concern documented in the official labeling. Regulatory documents mention that monitoring of weight is necessary, as documented risks include weight gain during long-term use. This risk is part of a broader set of metabolic changes that are regularly monitored.
Q: How quickly can someone expect Zyprexa to start working?
The onset of therapeutic effect observed in clinical trials can vary among individuals. According to regulatory documents, the oral formulation generally reaches its steady-state concentration (the point where the amount of drug entering the body equals the amount leaving) in about one week. The immediate-release injection is studied for use in acute situations and generally reaches its highest concentration in the bloodstream in less than an hour, as documented in regulatory sources.
Q: Are there any long-term health concerns associated with using Zyprexa?
Long-term concerns documented in official labeling primarily center on metabolic changes, which include significant weight gain, high blood sugar (hyperglycemia), and unhealthy lipid levels. There is also a risk of developing Tardive Dyskinesia, which is an involuntary movement disorder that may be long-lasting. Due to these risks, official guidelines specify the importance of regular monitoring of weight, blood glucose, and lipids.
Q: Is it safe to drive or operate machinery while taking this medication?
Official warnings state that the medication has the potential to impair judgment, thinking, and motor skills. The official warning states that caution should be exercised regarding operating hazardous machinery, including automobiles, until an individual knows how the drug affects their motor skills and judgment.
Q: Is it common for people to stop taking Zyprexa due to side effects?
Clinical trial data indicate that discontinuation rates specifically due to adverse events are documented. While these rates can vary, discontinuation is sometimes necessary, especially when used in combination with other mood stabilizers. Somnolence (sleepiness) and weight gain are frequently cited reasons for discontinuing the medication.
Q: Is it possible to take Zyprexa if I am lactose intolerant?
Official regulatory documents note that some dosage forms, specifically the Orally Disintegrating Tablets (ODT), contain lactose as an inactive ingredient. The standard oral tablets do not list lactose in the available references, but reviewing the excipients for any specific product is a necessary step for those with lactose intolerance.
Q: What are some common mental side effects people report with Zyprexa?
In addition to physical side effects, common adverse events reported include mental and cognitive changes. Postmarketing reports include side effects such as anxiety and insomnia (difficulty sleeping). Furthermore, the drug can elevate prolactin levels, which may be associated with changes in sexual function or desire.
Q: Do older adults take a different form of Zyprexa?
Official dosing guidelines advise a lower starting dose for older adults (age 65 or older) and those who may be sensitive to the drug. However, the guidelines do not require the use of a different dosage form, such as switching from a standard tablet to an orally disintegrating tablet.
Q: Is there a warning about taking Zyprexa during pregnancy?
Yes. Regulatory information states that babies exposed to olanzapine during the third trimester of pregnancy are at risk of developing extrapyramidal (involuntary movement issues) and/or withdrawal symptoms after delivery. The decision to use the drug during pregnancy is a clinical matter that involves a careful evaluation of the potential benefits versus the documented risk to the newborn.
Q: Can Zyprexa cause problems with cholesterol levels?
Yes. Official information documents that dyslipidemia, which involves undesirable alterations in blood fat profiles, including increased cholesterol and triglyceride levels, has been observed. To address this, testing of fasting blood lipids is a mandatory part of the monitoring protocol when starting and continuing treatment.
Q: Is Zyprexa a controlled substance?
No. Official regulatory documents from the FDA explicitly state that olanzapine is not classified as a controlled substance.
Q: What does official research say about the effectiveness of Zyprexa?
Clinical trials have been evaluated by regulatory agencies and found that olanzapine is effective for treating acute symptoms of schizophrenia and moderate to severe manic episodes in adults. it has also been evaluated for the prevention of mood episode recurrence in patients with bipolar disorder.
Q: What is the risk of movement disorders with Zyprexa?
The official safety information describes the risk of causing Tardive Dyskinesia, which is characterized by involuntary, uncontrollable movements, often of the face and tongue. Other movement-related events documented include akathisia (inner restlessness), parkinsonism (tremor and stiffness), and general tremor.
Q: How is Zyprexa different from older antipsychotic medications?
Olanzapine is classified as an Atypical Antipsychotic (Second-Generation) because of its differential receptor profile. Regulatory documents note that it acts as a dual antagonist of both dopamine and serotonin receptors. This mechanism distinguishes it from older, typical antipsychotics, which primarily focus on dopamine.
Q: Can Zyprexa make someone feel 'numb' or affect their personality?
Post-market surveillance reports collected by regulatory sources list a change in personality and a lack of feeling or emotion (emotional numbing) as less common side effects reported by some patients.
Q: What types of heart-related issues are described in the safety information for Zyprexa?
Documented heart-related issues include orthostatic hypotension, which is dizziness or light-headedness due to a sudden drop in blood pressure when standing up. Additionally, a Black Box Warning is in place regarding an increased risk of death (often due to cardiac causes) in elderly patients with dementia-related psychosis.
Q: Is it safe to use nicotine products while taking Zyprexa?
Regulatory documents explicitly state that smoking is a CYP1A2 inducer, which is documented to decrease the plasma levels of olanzapine in the blood. This reduction in the drug's concentration may potentially lessen its intended therapeutic effect.
Q: Can Zyprexa be taken with other psychiatric medications?
Yes. Official labeling includes indications for olanzapine's use in combination with certain other psychiatric medications. Specifically, it is approved to be used as an adjunct (additional treatment) to valproate or lithium, and in combination with fluoxetine (an antidepressant) for specific types of depression.
Q: Is there a potential for withdrawal symptoms if Zyprexa is stopped suddenly?
Official guidance notes that olanzapine is generally tapered gradually (slowly reduced) when discontinuing treatment to manage potential symptoms. Stopping abruptly may lead to the occurrence of acute symptoms such as sweating, insomnia, tremor, anxiety, or nausea.
Q: Does Zyprexa affect sleep patterns?
Yes. Somnolence (sleepiness) is listed as a very common side effect in official information. Other sleep-related effects reported include insomnia (difficulty falling or staying asleep) and general trouble sleeping.
Q: Does the time of day a person takes Zyprexa matter?
The oral form is intended for once-daily intake and can be administered without regard to meals. Since sleepiness is a very common side effect, it is often taken in the evening to allow the sedation to occur while the patient is resting, although the label does not mandate a specific time.
Q: Is it necessary to take Zyprexa with food?
No. The official prescribing information states that the oral form of olanzapine may be administered without regard to meals. This means it can be taken with food or on an empty stomach.
Q: What should a patient do if they experience vision changes while on Zyprexa?
Official information lists blurred vision and impaired vision as common side effects of the medication. As vision changes are documented side effects, any concerning adverse reaction requires communication with a healthcare professional.
Q: What does the research suggest about Zyprexa and mood stabilization?
Official research supports the use of olanzapine for the treatment of moderate to severe manic episodes and for the prevention of recurrence of mood episodes in patients diagnosed with bipolar disorder. These documented uses align with a mood-stabilizing effect within those specific conditions.
Q: What is the typical duration of treatment with Zyprexa, according to studies?
The acute phase of treatment in clinical trials typically lasted from 3 to 6 weeks. For patients who respond favorably, official guidance supports its use for continuation therapy to maintain clinical improvement and help prevent recurrence. Therefore, treatment duration can be long-term, depending on the clinical decision.
Q: Does Zyprexa affect fertility?
Official information notes that olanzapine can elevate prolactin levels in the blood. In women, high prolactin levels can potentially stop ovulation (the release of an egg), which may be a documented fertility concern. This effect is a documented risk.
Q: Why are people often told to watch their diet when taking Zyprexa?
The regulatory documents highlight a significant risk of weight gain and other metabolic changes such as high blood sugar and cholesterol. Due to these serious risks, official documentation indicates that monitoring advice often includes an emphasis on diet and exercise to help manage the risk of metabolic changes.
Q: Does official information mention hair loss as a possible side effect of Zyprexa?
Yes. Alopecia (hair loss) is listed as an infrequent adverse event in the official postmarketing reports section of the regulatory documents.
Q: What is the expected time for the major side effects of Zyprexa to appear?
The time it takes for side effects to appear varies greatly. Common side effects like sleepiness often occur during the initial dosing period. In contrast, a serious skin reaction called DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) has a documented median time to onset of approximately 19 days after treatment begins.
Q: Is there a risk of fever or extreme muscle stiffness with Zyprexa?
Yes. The official safety information describes the risk of a serious, rare condition called Neuroleptic Malignant Syndrome (NMS). NMS is a potentially fatal condition that includes symptoms such as a very high fever and severe muscle rigidity.
Q: Is Zyprexa used in combination with antidepressants?
Yes. Official labeling includes indications for its use in combination with fluoxetine, which is an antidepressant. This combination is specifically indicated for treating depressive episodes associated with bipolar I disorder and for treatment-resistant depression.
